Robert Mittendorff

Robert Mittendorff, MD, MBA, currently serves as General Partner and Global Head of Healthcare at B Capital Group since March 2021. Additionally, Robert holds various board observer and director roles at several companies including Evommune, Nuvig Therapeutics Inc., Nalu Medical, Inc., Capital Rx, CARRICK THERAPEUTICS UK LIMITED, Carlsmed, Lively, Inc., HotSpot Therapeutics, Inc., and Triumvira Immunologics, Inc. Educational qualifications include an MBA from Harvard Business School, an MD from Harvard Medical School, a Master of Arts in International Affairs from King's College London, a B.S. in Biomedical/Electrical Engineering with high honors from The Johns Hopkins University, and completion of the Emergency Medicine Residency Program at Stanford University School of Medicine. Robert also pursued graduate studies in Systems Engineering and Financial Engineering at the Massachusetts Institute of Technology.